Literature DB >> 33463858

Self-concept and health anxiety relate to psychological outcomes for BRCA1/2 carriers.

Ellen Butler1, Sonya Collier2, Michael Boland3, Yvonne Hanhauser3, Elizabeth Connolly3, David Hevey1.   

Abstract

OBJECTIVE: Leventhal's common sense model of self-regulation highlights how specific beliefs about illness influence psychological outcomes. Little is known on how such beliefs relate to BRCA1/2 adjustment. Furthermore, beliefs about one's self-concept may be relevant to genetic conditions and may relate to psychological wellbeing.
METHODS: One-hundred and eighteen female BRCA1/2 carriers from an Irish University Hospital completed questionnaires for this cross-sectional study. Outcomes measured were state anxiety and physical and mental health-related quality of life (HRQOL). Explanatory variables included sociodemographics, health anxiety, illness perceptions, coping and self-concept. Hierarchical multiple regression analyses were conducted.
RESULTS: Then, 44% of participants had clinically significant state anxiety and 12% had clinically significant health anxiety. Vulnerability, stigma, mastery and health anxiety explained 42% of the variance in state anxiety. Previous mental health difficulty, vulnerability, stigma, mastery and health anxiety explained 40% of the variance in mental HRQOL. Dysfunctional coping strategies were strongly related to the physical functioning aspect of quality of life.
CONCLUSION: BRCA-specific beliefs related to self and health anxiety are important factors to consider in the adjustment to BRCA1/2 confirmation.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  BRCA1/2; anxiety; common sense model; coping; genetic testing; oncology; psychological; psycho‐oncology; quality of life; self‐concept

Year:  2020        PMID: 33463858     DOI: 10.1002/pon.5483

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  1 in total

Review 1.  Helping Patients Understand and Cope with BRCA Mutations.

Authors:  Sukh Makhnoon; Banu Arun; Isabelle Bedrosian
Journal:  Curr Oncol Rep       Date:  2022-03-18       Impact factor: 5.945

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.